Idexx Laboratories
IDXX
376 hedge funds and large institutions have $6.76B invested in Idexx Laboratories in 2016 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 114 increasing their positions, 134 reducing their positions, and 22 closing their positions.
127% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 22
10% more funds holding in top 10
Funds holding in top 10: 10 → 11 (+1)
7% more funds holding
Funds holding: 350 → 376 (+26)
3% more capital invested
Capital invested by funds: $6.55B → $6.76B (+$215M)
15% less repeat investments, than reductions
Existing positions increased: 114 | Existing positions reduced: 134
86% less call options, than puts
Call options by funds: $2.98M | Put options by funds: $20.6M
Top Buyers
| 1 |
Fundsmith LLP
London,
United Kingdom
|
+$124M |
| 2 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$75.5M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$47.4M |
| 4 |
Two Sigma Investments
New York
|
+$28M |
| 5 |
Renaissance Technologies
New York
|
+$22.3M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$246M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$55.7M |
| 3 |
CC
Capital Counsel
New York
|
-$49M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$28.4M |
| 5 |
Select Equity Group
New York
|
-$26.8M |
IDXX Hedge Fund Activity: Q1 2016 in Review
376 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q1 2016, worth a combined $6.76B — up 3.3% from $6.55B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new IDXX positions and 22 closed out — a net gain of 28 holders — while 114 added to existing stakes and 134 trimmed.
The largest buyer was Fundsmith LLP, adding an estimated $124M. The largest seller was T. Rowe Price Associates, cutting an estimated $246M.
- 376 institutional investors held Idexx Laboratories (IDXX) as of Q1 2016, up from 350 in Q4 2015.
- Funds reported $6.76B of Idexx Laboratories stock for Q1 2016, up 3.3% quarter-over-quarter.
- 50 funds opened new Idexx Laboratories positions in Q1 2016 and 22 closed out, a net change of +28 holders.
- The largest Idexx Laboratories buyer in Q1 2016 was Fundsmith LLP, an estimated $124M added.
- The largest Idexx Laboratories seller in Q1 2016 was T. Rowe Price Associates, an estimated $246M sold.
Based on aggregated 13F filings for Q1 2016.